Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.
Título
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.
Autor
Julia V Wanschitz, Manuela Kaml, Bettina Pfausler, Raimund Helbok, Sophie Wildner, Gerlig Widmann, Sabina Sahanic, Florian Deisenhammer, Wolfgang N Löscher, Markus Reindl, Judith Löffler-Ragg, Ronny Beer
Fecha
2020
Identificador
10.1007/s00415-020-10310-x
Fuente
Journal of neurology
Archivos
Colección
Citación
Julia V Wanschitz, Manuela Kaml, Bettina Pfausler, Raimund Helbok, Sophie Wildner, Gerlig Widmann, Sabina Sahanic, Florian Deisenhammer, Wolfgang N Löscher, Markus Reindl, Judith Löffler-Ragg, Ronny Beer, “Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.,” SOCICT Open, consulta 20 de abril de 2026, https://socictopen.socict.org/items/show/8141.
Position: 20379 (12 views)